HomeONC • TSE
Oncolytics Biotech Inc
$1.44
Mar 28, 2:33:10 PM GMT-4 · CAD · TSE · Disclaimer
StockCA listed securityCA headquartered
Previous close
$1.38
Day range
$1.39 - $1.44
Year range
$1.20 - $4.49
Market cap
107.17M CAD
Avg Volume
73.44K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
(CAD)Dec 2023Y/Y change
Revenue
Operating expense
8.85M4.01%
Net income
-3.95M53.83%
Net profit margin
Earnings per share
-0.1125.75%
EBITDA
-8.83M-4.05%
Effective tax rate
-1.10%
Total assets
Total liabilities
(CAD)Dec 2023Y/Y change
Cash and short-term investments
34.91M8.63%
Total assets
38.82M3.98%
Total liabilities
11.26M3.92%
Total equity
27.56M
Shares outstanding
75.42M
Price to book
3.73
Return on assets
-52.11%
Return on capital
-76.92%
Net change in cash
(CAD)Dec 2023Y/Y change
Net income
-3.95M53.83%
Cash from operations
-6.12M-3.12%
Cash from investing
-3.00K99.99%
Cash from financing
1.74M-70.32%
Net change in cash
-5.07M75.51%
Free cash flow
-8.14M-349.09%
About
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Founded
1998
Employees
29
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu